OncoCyte Corp Correlations
OCX Stock | USD 3.30 0.20 5.71% |
The current 90-days correlation between OncoCyte Corp and Burning Rock Biotech is -0.06 (i.e., Good diversification). The correlation of OncoCyte Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
OncoCyte Corp Correlation With Market
Good diversification
The correlation between OncoCyte Corp and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and DJI in the same portfolio, assuming nothing else is changed.
OncoCyte |
Moving together with OncoCyte Stock
0.92 | CMRX | Chimerix Sell-off Trend | PairCorr |
0.72 | CPIX | Cumberland Pharmaceuticals | PairCorr |
0.65 | LUCD | Lucid Diagnostics Buyout Trend | PairCorr |
0.81 | PKX | POSCO Holdings | PairCorr |
Moving against OncoCyte Stock
0.91 | GKOS | Glaukos Corp | PairCorr |
0.78 | SNDL | SNDL Inc | PairCorr |
0.78 | ELMD | Electromed | PairCorr |
0.73 | MOLN | Molecular Partners | PairCorr |
0.7 | CLDX | Celldex Therapeutics | PairCorr |
0.58 | VOR | Vor Biopharma | PairCorr |
0.53 | IPA | Immunoprecise Antibodies | PairCorr |
0.49 | EYEN | Eyenovia | PairCorr |
0.44 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.42 | RGEN | Repligen Potential Growth | PairCorr |
0.42 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.86 | LIVN | LivaNova PLC | PairCorr |
0.84 | ITGR | Integer Holdings Corp | PairCorr |
0.79 | APYX | Apyx Medical | PairCorr |
0.75 | MODD | Modular Medical | PairCorr |
0.71 | INGN | Inogen Inc | PairCorr |
0.59 | OTRK | Ontrak Inc | PairCorr |
0.58 | MDAI | Spectral AI | PairCorr |
0.49 | SGHT | Sight Sciences | PairCorr |
0.48 | NPCE | Neuropace | PairCorr |
0.39 | AXDX | Accelerate Diagnostics Earnings Call This Week | PairCorr |
0.82 | KB | KB Financial Group | PairCorr |
0.81 | SRDX | SurModics | PairCorr |
0.77 | CNMD | CONMED | PairCorr |
0.74 | HYMTF | Hyundai Motor | PairCorr |
0.67 | RKV | Rakovina Therapeutics | PairCorr |
0.39 | CCLDP | CareCloud | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between OncoCyte Stock performing well and OncoCyte Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OncoCyte Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BNR | 3.83 | (0.16) | 0.00 | (0.34) | 0.00 | 8.52 | 26.46 | |||
STIM | 6.97 | 2.65 | 0.36 | 2.83 | 5.84 | 18.78 | 51.44 | |||
DRIO | 6.25 | 0.53 | 0.06 | (2.38) | 8.91 | 11.29 | 121.18 | |||
GTH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
SERA | 3.36 | (0.93) | 0.00 | (0.79) | 0.00 | 5.72 | 26.54 | |||
OLK | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
FONR | 1.34 | (0.13) | 0.00 | (0.29) | 0.00 | 2.50 | 10.83 | |||
CSTL | 2.47 | (0.47) | 0.00 | (2.04) | 0.00 | 4.51 | 23.81 | |||
XGN | 5.08 | 0.03 | 0.00 | (0.06) | 0.00 | 15.86 | 42.16 | |||
PSNL | 5.65 | 0.54 | 0.06 | 0.07 | 5.62 | 9.82 | 61.04 |
OncoCyte Corp Corporate Management
Andrea James | Chief Officer | Profile | |
Ekkehard MD | Chief Officer | Profile | |
Joshua Riggs | Interim Officer | Profile | |
Tony Kalajian | Senior Vice President Chief Accounting Officer | Profile | |
Andrew Last | Independent Director | Profile | |
William Annett | Advisor | Profile |